Bamford M J, Chan C, Craven A P, Dymock B W, Green D, Henson R A, Kirk B E, Lester M G, Procopiou P A, Snowden M A
Glaxo Research and Development Ltd., Medicines Research Centre, Stevenage, Hertfordshire, UK.
J Med Chem. 1995 Sep 1;38(18):3502-13. doi: 10.1021/jm00018a010.
A series of squalestatins modified at the C3-position with a heterocyclic functionality was prepared and evaluated in vitro as inhibitors of squalene synthase (SQS). Structure-activity relationships for compounds with the 4,6-dimethyloctenoate at C6(S1 analogues) were different from those for analogues lacking the C6 ester (H1 analogues), with a greater dependence on the nature of the C3-substituent for the H1 series. Potent SQS inhibitory activity equivalent to that of H1 is retained by a C3-(tetrazol-5-yl) analogue, i.e., a carboxylic acid mimetic. The C3-methyl ester derivative is 10-fold less active than H1, and SQS inhibitory activity similar to that of the methyl ester was retained only in those C3-heterocycle-substituted H1 analogues for which electrostatic potential maps of the C3-substituent were closely similar to that of a methyl ester.
制备了一系列在C3位带有杂环官能团修饰的鲨烯他汀,并在体外作为鲨烯合酶(SQS)抑制剂进行了评估。C6位带有4,6-二甲基辛烯酸酯的化合物(S1类似物)的构效关系与缺乏C6酯的类似物(H1类似物)不同,H1系列对C3取代基性质的依赖性更大。一种C3-(四唑-5-基)类似物(即一种羧酸模拟物)保留了与H1相当的强效SQS抑制活性。C3-甲酯衍生物的活性比H1低10倍,并且仅在那些C3-杂环取代的H1类似物中保留了与甲酯相似的SQS抑制活性,这些类似物的C3取代基的静电势图与甲酯的静电势图非常相似。